TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Karo Pharma Sverige AB
Closing information (x1000 EUR)
Closing information | 2021/12 | 2020/12 | 2019/12 |
Turnover |
27,078
|
22,787
|
28,134 |
Financial expenses |
34
|
13
|
15 |
Earnings before taxes |
-1,596
|
-1,240
|
-102 |
EBITDA |
-1,535
|
-8,195
|
803 |
Total assets |
28,975
|
29,765
|
15,109 |
Current assets |
28,904
|
29,653
|
10,546 |
Current liabilities |
7,901
|
6,632
|
10,821 |
Equity capital |
21,074
|
23,123
|
4,278 |
- share capital |
15
|
16
|
15 |
Employees (average) |
129
|
93
|
40 |
Financial ratios
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Solvency |
72.7%
|
77.7%
|
28.3% |
Turnover per employee |
210
|
245
|
703 |
Profit as a percentage of turnover |
-5.9%
|
-5.4%
|
-0.4% |
Return on assets (ROA) |
-5.4%
|
-4.1%
|
-0.6% |
Current ratio |
365.8%
|
447.1%
|
97.5% |
Return on equity (ROE) |
-7.6%
|
-5.4%
|
-2.4% |
Change turnover |
4,713
|
-6,457
|
103 |
Change turnover % |
21%
|
-22%
|
0% |
Chg. No. of employees |
36
|
53
|
11 |
Chg. No. of employees % |
39%
|
133%
|
38% |
Total value of public sale
Fiscal year | 2021/12 | 2020/12 | 2019/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.